International Journal of Infectious Diseases (Jul 2023)

Characteristics and clinical effectiveness of COVID-19 vaccination in hospitalized patients in Omicron-dominated epidemic wave – a nationwide study in Japan

  • Hiromu Tanaka,
  • Shotaro Chubachi,
  • Takanori Asakura,
  • Ho Namkoong,
  • Shuhei Azekawa,
  • Shiro Otake,
  • Kensuke Nakagawara,
  • Takahiro Fukushima,
  • Ho Lee,
  • Mayuko Watase,
  • Kaori Sakurai,
  • Tatsuya Kusumoto,
  • Katsunori Masaki,
  • Hirofumi Kamata,
  • Makoto Ishii,
  • Naoki Hasegawa,
  • Yukinori Okada,
  • Ryuji Koike,
  • Yuko Kitagawa,
  • Akinori Kimura,
  • Seiya Imoto,
  • Satoru Miyano,
  • Seishi Ogawa,
  • Takanori Kanai,
  • Koichi Fukunaga

Journal volume & issue
Vol. 132
pp. 84 – 88

Abstract

Read online

Objectives: COVID-19 was severe in the Delta variant-dominated epidemic wave (fifth wave) in Japan. The clinical characteristics and effectiveness of COVID-19 vaccination are not fully understood in the Omicron variant-dominated wave (sixth and seventh waves), especially in hospitalized patients. We investigated the relationship between vaccination and disease severity in the Omicron-dominated wave and compared these variant-dominated waves. Methods: The nationwide COVID-19 database (Japan COVID-19 Task Force) was used to compare clinical characteristics and critical outcomes in patients hospitalized with Delta (fifth, N = 735) vs Omicron-dominated waves (sixth, N = 495; seventh, N = 128). Results: Patients in the sixth and seventh waves had a lower incidence of critical outcomes and respiratory outcomes, and a higher incidence of bacterial infection, although the mortality rate did not differ significantly between waves. In the sixth and seventh waves, 138 (27.9%) and 29 (22.7%) patients with COVID-19 were unvaccinated, respectively. Multivariable analysis adjusted with previously reported factors revealed that the proportion of (1) critical outcomes and (2) respiratory outcomes decreased in a frequency-dependent manner. Thus, (1) (the number of vaccinations): 1-2 times: adjusted odds ratio (aOR) 0.37 (95% confidence interval [CI]; 0.20-0.69); 3-4 times: aOR 0.25 (95% CI; 0.11-0.58); and (2) 1-2 times: aOR 0.43 (95% CI; 0.27-0.66); 3-4 times: aOR 0.36 (95% CI; 0.21-0.60). Conclusions: Patients hospitalized with COVID-19 with Omicron infections showed a lower incidence of critical outcomes than those with Delta infections, and COVID-19 vaccination may contribute to preventing respiratory failure.

Keywords